Recruiting

Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection Surgery

ClinicalTrials.gov IDNCT07001670

PhaseNA

Enrollment40

SponsorIstanbul University

Age18 Years

SexALL

I'm interested View official listing

Conditions studied

Postoperative Period, Lung Cancer (Diagnosis)

About this study

This randomized controlled clinical trial aims to evaluate the effects of an 8-week tele-yoga intervention in individuals with lung cancer who have undergone lung resection surgery. The intervention group will receive supervised yoga sessions via online synchronous video conferencing, while the control group will continue with standard post-operative care. The primary outcome is exercise capacity (6-minute walk test), with secondary outcomes including pulmonary function, respiratory and peripheral muscle strength, physical activity level, dyspnea, fatigue, sleep quality, anxiety and depression, and quality of life. It is hypothesized that tele-yoga will improve physical and psychological recovery post-surgery and may serve as a feasible home-based pulmonary rehabilitation alternative.

Interventions

Other: Tele-Yoga Training — The Tele-yoga group will participate in real-time yoga sessions three times a week for eight weeks, including individual sessions for the first two weeks and small group sessions for the remaining six weeks, with all sessions supervised by a certified instructor. Each session will last approximately 45-60 minutes and include a 5-10 minute warm-up, 15-20 minutes of yoga postures, 15-20 minutes of yogic breathing exercises, and 5-10 minutes of relaxation and meditation.

Primary outcomes

The Six-Minute Walk Test (6MWT) (Change from Baseline at 8 weeks)

Eligibility information

Inclusion Criteria: * Aged between 18 and 65 years, * Histologically confirmed diagnosis of Stage I-IIIA lung cancer according to the 9th edition of the AJCC Cancer Staging Manual, * Underwent lobectomy, pneumonectomy, segmentectomy, or wedge resection via video-assisted thoracoscopic surgery (VATS) or robot-assisted thoracoscopic surgery (RATS), * An estimated life expectancy of ≥6 months, * Karnofsky Performance Status score greater than 80% at study entry, * Possession of the necessary equipment and access to a stable internet connection to enable participation in online interventions. Exclusion Criteria: * History of receiving radiotherapy or chemotherapy prior to surgery, * Presence of severe dysfunction in vital organs such as the heart, brain, kidneys, or others, * Having any comorbid condition that contraindicates participation in an exercise training program, * Presence of serious postoperative complications, * Cognitive impairments that hinder effective communication, * Current participation in a structured and regular exercise program, * Missing three consecutive weeks of sessions or completing less than 75% of the prescribed exercises, * Voluntary withdrawal from the study by the participant.

Study locations

Department of Thoracic Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey (Türkiye)

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.